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A subfraction of human blood lymphocytes can lyse certain established cell lines in 
tissue  culture  in short-term  assays  (1-4).  The system is  similar  to the  natural  killer 
(NK) x cell  system  in  rats  and  mice  (5,  6).  Unlike cytotoxic T  cells  directed  against 
virally determined antigens or haptens, NK cells do not appear to be under any major 
histocompatibility complex restriction  (7). The NK effect is exerted by a subset within 
the T-cell lineage (8-10). Most, but not all of them, carry Fc receptors (8,  11,  12) and 
some carry C3 receptors as well  (12,  13). 
The panel  of highly NK-sensitive  cell  lines  in  men  and  mice shows  a  somewhat 
erratic pattern. T  cell-derived human lymphoid lines are often more sensitive than B 
cell-derived  lines.  NK  activity  in  mice  was  found  to  increase  after  virus  infection, 
treatment  of the effector cells with  interferon  or interferon  inducers,  and tumor-cell 
inoculation  (14-16).  Several  recent  reports  suggest  that  viral  infection of the  target 
cells increases their NK sensitivity  (17,  18).  Highly NK-active nude mice were found 
to  reject  persistently  virus-infected  tumor  cells,  in  contrast  to  their  noninfected 
counterparts  (19), this rejection was attributed  to NK cells. 
It is thus conceivable, and even likely, that NK cells play a  role in restricting viral 
infections by attacking virally infected cells and nipping them in the bud, as it were. 
Although the evidence for such an effect is highly suggestive, it is far from conclusive. 
This paper addresses itself to the question of whether NK cells may play a  role in 
restricting  the  spread  of a  virus  that  has  prolonged  latency  as  a  major  part  of its 
natural  life  cycle,  with  only  occasional  entry  of the  virus-carrying  cells  into  the 
productive cycle. If NK cells play any restrictive role in limiting virus spread, it could 
be  expected  that  they  would  kill  cells  that  have  already  entered  the  cycle  more 
efficiently than cells that carry the viral genome in a  latent state. 
Epstein-Barr  virus  (EBV),  a  lymphotropic  herpesvirus  in  man,  appears  to  be 
particularly well suited for the study of this question. In primary infection, as it occurs 
in infectious mononucleosis, it infects B lymphocytes and converts them into Epstein- 
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Barr-virus-determined  nuclear  antigen  (EBNA)  positive cells.  The patients  respond 
with  antibody  production  against  viral  capsid  antigen  (VCA),  early  antigen  (EA) 
and, eventually,  against  EBNA in that temporal order.  Later, as the acute infection 
subsides,  the  number of virus-carrying cells  falls  (20)  and  stays  at  a  low  level  in  a 
latent  form over a  patient's lifetime. After the acute disease, antibodies against VCA 
and EBNA persist, whereas the anti-EA response fades away. 
The mechanisms that keep the number of virus-producing cells at a  relatively low 
level  are  not  known.  If NK  cells  play  a  role,  one  would  expect  that  EBV-DNA- 
carrying cells that  have entered  the viral cycle would be more sensitive  to NK lysis 
than the progenitor cells that carry the viral genome in a  latent form. 
EBV-earrying  lymphoblastoid  and  Burkitt's  lymphoma-derived  lines  all  contain 
the viral genome in multiple copies (21-23), and express EBNA (24). However, only 
a  very small proportion, if any, of the cells enter the viral cycle at a  given time. This 
proportion can be dramatically increased,  however, by superinfecting  EBV-carrying 
cultures  with  massive  doses of the  P3HR-1  substrain  of EBV  (25), or by treatment 
with certain chemical inducers, such as n-butyrate (26-30). 
In  this  paper,  we  show  that  both  methods  of EBV-cycle  induction  lead  to  an 
increase in the NK sensitivity of EBV-carrying cell lines. Interestingly, superinfection 
with a  transforming virus prototype,  B95-8, which does not increase  the  fraction of 
cells entering the viral cycle, had no such effect (with one exception). 
Materials  and Methods 
Virus.  Infectious EBV from the P3HR- 1 cell line was provided by the Pfizer Chemical Div., 
Pfizer,  Inc., New York, under a contract from the Division of Cancer Cause and Prevention, 
National Cancer Institute, National Institutes of Health, Bethesda, Md. 
The virus was received in wet pack, frozen, and stored at -70°C. These preparation usually 
induced 20-30% EA-positive cells in the Raji line 48 h after superinfection with a 1:75 dilution. 
B95-8 virus was concentrated by centrifugation at 9,000 rpm for 2 h from the supernate of B95- 
8 cells;  it was frozen and stored at  -70°C.  Its infectivity was assayed by exposing the EBV- 
negative Ramos cell line to 1:5 and  1:10 dilutions; 24-27% EBNA-positive cells were induced 
after 48 h  (31). 
Cell Lines.  All cells were propagated as suspension cultures in RPMI-1640 medium with 8% 
fetal  calf serum  (Grand  Island  Biological Co.,  Grand  Island,  N.  Y.)  and  subcuhured  twice 
weekly.  Raji (32) and Daudi (33) originated from Burkitt's lymphoma, B  JAB (34) was derived 
from an EBV-negative Burkitt's lymphoma, Molt-4 (35) was derived from an acute lymphocytic 
leukemia patient,  K562  (36) was established  from a  patient  with chronic myeloid leukemia. 
Both AT-A-CL7-III and NAD-7 were established in our laboratory, by transforming the blood 
lymphocytes of an ataxia teleangiectasia  patient  and a  healthy adult.  Both lines  were trans- 
formed with the B95-8 strain of EBV. 
Superinfection of Cells.  Cells were suspended at a concentration of 1 X  10  6 per ml and infected 
with the appropriately diluted  virus for  1 h  at  37°C. The cells were resuspended  in culture 
medium  at  a  concentration  of 0.5  ×  106  per  ml  and  incubated  at  37°C  for  24  h.  Cells 
superinfected with P3HR-1 virus are designated by adding the symbol (V). 
Demonstration of EBV-associated Antigens.  EA was stained  on acetone-fixed smears with  an 
fluorescein isothiocyanate-conjugated IgG fraction of EA- and VCA-positive human serum at 
a  dilution  of  1:40  as  previously  described  (37).  EBNA  was  stained  by  anti-complement 
immunofluorescence on methanol-acetone-fixed smears (24). 
Lymphocytes.  Lymphocytes were separated from heparinized blood by the Ficoll  (Pharmacia 
Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.)  -Isopaque (Nyeggard, & Co. AS, 
Oslo, Norway) method of B6yum (38). 
Cytotoxic Assay.  ~XChromium release  tests were performed in a Falcon II microplate (Falcon 
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(PBL) were used as effector cells at a  100:1 effector target ratio. 5 ×  10  a target cells were added 
to each well in a vol of 0.1 ml followed by the addition of 5 ×  105 PBL per 0.1 ml. Finally, 0.1 
ml  medium was added to each well to give a  final concentration of 0.3  ml  per well. Test 
combinations were set  up  in quadruplicate. Control wells containing only target cells were 
included in each experiment to determine maximum and spontaneous release. The microplate 
was  incubated  at  37°C  in  a  5%  CO2  atmosphere  for 4  h.  After incubation,  the plate was 
centrifuged at 1,500 rpm for 5 min. 0.1 ml of the cell-free supemate was removed. The specific 
51Cr release was determined according to the following formula: 
release in test -  spontaneous release 
x  100. 
maximal release -- spontaneous release 
Experiments in which the spontaneous release was >25% were not evaluated. 
Cold-Target Inhibition of Cytotoxicity.  The cytotoxic test was performed as above after graded 
numbers of unlabeled cells were added simultaneously with the target cells in 0.1 ml medium. 
The microplate was rocked on a  Bellco (Bellco Glass, Inc., Vineland, N. J.)  rocker at a slow 
speed  during  the  duration  of the  assay.  The  results  were  expressed  as  the  percentage  of 
inhibition. 
Induction of Cells by n-Butyrate.  3 mM n-butyrate was added to P3HR-1  cells suspended at a 
concentration of 0.4 ×  10~  per ml for various time intervals. 
Virus Neutralization.  P3HR-1  virus was incubated with  l:10 anti-EBV (VCA) -positive or 
-negative sera at 4°C  for 2.5  h. The final concentration of the virus was the same as in the 
superinfection experiments. After incubation, the infection experiment was performed as usual. 
Kinetics.  Aiiquots of Raji cells from one pool were removed and infected at different time 
intervals  with  the  P3HR-1  virus  derived  from  the  same  batch.  All  cells  were  harvested 
simultaneously, 51Cr labeled, and exposed to the same effector lymphocytes. 
Results 
P3HR-1  Virus Superinfection  Increases  the NK Sensitivity  of Raft  Cells.  Raji  cells are 
relatively resistant to NK killing (40). EBV  (P3HR-1  strain) superinfection increases 
the  NK  sensitivity of Raji  cells  after  24  h  (Fig.  1).  This  was  observed  in  all  25 
experiments  that  were  carried  out.  The  mean  percent  specific  chromium  release 
increased from 3.4 to 27%. There was no increase of the background 51Cr release. The 
addition of human serum instead of fetal calf serum did not influence the results. Raji 
cells superinfected  with  different  concentrations  of virus  showed  increased  specific 
51Cr release depending on the virus concentration  (Fig. 2). 
The Virus-induced  Increase in NK Sensitivity Depends on the Efficiency of Infection.  P3HR- 
1 virus superinfection induced the entry of a  certain proportion of Raji cells into the 
viral  cycle,  as  indicated  by  the  appearance  of EA.  To  examine  if there  was  any 
relationship  between  the  efficiency of the  superinfection,  as  measured  by  the  EA- 
induction criterion, and the increased NK sensitivity, aliquots of the culture tested for 
NK sensitivity were fixed 48  h  after infection and the frequency of EA-positive cells 
was determined. The relationship between the frequency of EA-positive cells and NK 
sensitivity is shown in Fig. 3. The results suggest that the sensitivity of the target cells 
depends on the initiation of the viral cycle (although not necessarily on EA synthesis 
as such). 
Virus Neutralization  Test.  Because superinfection was carried out with concentrated, 
virus-containing P3HR-1  culture supernate and not with purified virus, it had to be 
checked  whether  the  virus  itself could  be  held  responsible  for  the  increased  NK- 
sensitivity. Infection tests were therefore also performed with preparations exposed to 
EBV  antibody-positive human  serum,  for  2½  h  before  infection  (Table  I).  EBV 
antibody-positive, but not negative, serum abolished the ability of the virus-containing B.  BLAZAR, M.  PATARROYO,  E.  KLEIN,  AND G.  KLEIN 
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FIG.  1.  Cytotoxic effect of human blood lymphocytes  on Raji (V) cells. The cells superinfected in 
fetal calf serum (FCS)- and in human serum (HS)-c0ntaining medium are shown for comparison. 
Each point represents a different experiment, for each target cell. Means and standard errors are 
shown. The cytotoxicity was measured as percent specific chromium release at a  100:1 effector: 
target cell ratio in a 4-h assay, 24 h after infection. The mean percent spontaneous release was 18.2 
:t: 3.6 for uninfected and 18.5 :t: 3.6 for Raji (V) cells, in 25 experiments. 
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supernates to increase the NK sensitivity, indicating that the virus was responsible for 
the effect. 
Changes in NK Sensitivity in Raft Cells as a Function of Time After Superinfection.  The 
NK sensitivity of P3HR-l-virus-superinfected  Raji cells increased by 12 h, peaked at 
24 h, and declined subsequently (Fig. 4). Because viral attachment to the EBV surface 
receptors is maximal immediately after the infection (41) and declines thereafter, the 
sensitivity is not merely a  result of the presence of attached virus particles on the cell 
surface. 
Superinfection of Other Cell Lines.  Four other lymphoid lines were also superinfected 
with P3HR-1 virus. EA induction served as the measure of successful infection. The 
different  cell  lines  varied  both  with  regard  to  the  induction of  EA  and  of  NK 
sensitivity. Experiments with the lymphocytes of two donors differing in NK efficiency 
are given as examples in Table II. 
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Fxc. 2.  Relationship  between the percentage specific 5~Cr release and the concentration  of the 
virus preparation used for superinfection. Virus dilution ranged from 1:25 to 1:300. Effector:target 
cell ratio:  100:1. NK sensitivity was measured in a 4-h chromium release assay, 24 h after infection. 
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FIG. 3.  Relationship between percentage of EA-positive cells and NK-related cytotoxicity in Raji 
(V) cells. Each point represents a different experiment.  Virus dilution  ranged between  1:5 and 1: 
150. Effector:target cell ratio:  100:1. Sensitivity was measured in a 4-h chromium release assay, 24 
h after infection. The frequency of EA-positive cells was determined on acetone-fixed smears, 48 h 
after infection. 
assumed  that  the  increased NK  sensitivity of the EBV-superinfected  Raji cells is a 
result of the recognition of EBV-associated antigens by immune  lymphocytes, or of 
an  antibody-dependent cell-mediated (ADCC)  mechanism.  In  the latter case, anti- 
bodies would be secreted during incubation. Therefore the cytotoxicity of effector cells 
derived from EBV-seropositive and seronegative donors was compared in four exper- 
iments  (Table III). There was  no significant difference between  the killing effect of 
cells from EBV,positive and -negative donors. Thus, although EBV is responsible for 
the  induction  of  NK  sensitivity  (as  indicated  by  the  virus  neutralization  test), 
cytotoxicity is not a  result of a  preimmunized state of the lymphocyte donor against 
EBV. 
Cold-Target  Inhibition  Tests.  The  question  arose whether  the  killing of the  EBV- 
superinfected Raji was a  result of the effector-target interaction operating also in the B.  BLAZAR, M.  PATARROYO,  E.  KLEIN,  AND G.  KLEIN 
TABLE I 
Virus Neutralization  Before Superinfection  Prevents Increased NK Sensitivity 
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Percentage of  Percentage of 
Cells  Virus treatment  EA  specific ~Cr 
release 
%  % 
Raji control  1  3 
Raji (V)  --  43  31 
Raji  Infected with virus exposed to EBV  29  25 
antibody-negative serum 
Raji  Infected with virus exposed to EBV  12  5 
antibody-positive serum 
P3HR-I virus was incubated  with EBV antibody-positive serum (VCA titer:  160, 
EA: <  10, EBNA: 80) and EBV antibody-negative serum (VCA titer: <  10, EA: < 




i  f2  z4  3s  4e  hours 
Fro. 4.  Time-course of the acquisition of sensitivity to the  lymphocyte killing. Raji cells taken 
from one constant pool were infected at varying time intervals by aliquots from one P3HR-I virus 
preparation.  These populations  Raji  (V)  (O)  and  Raji  (0)  were simultaneously harvested and 
assayed with the same effector lymphocytes. 
known human NK system. As one approach toward this question, we have performed 
cold target  inhibition  tests  with  two cell  lines  known  for their  high  NK-sensitivity, 
Molt-4 and K562. The cell populations used for competition were tested for their NK 
sensitivity in parallel.  We could readily confirm the high NK sensitivity of these lines 
(specific 51Cr release: 35-40% at a  100:1 effector:target cell ratio). B  JAB had low NK 
sensitivity (6-9%), Daudi and Raji were even lower (1-3%), and NAD-7 was insensitive 
(0-1%).  In the competition  test,  cytotoxicity against  Raji  (V)  was  inhibited  by the 
homologous cell,  Raji  (V)  itself,  and  by Molt-4 and  K562  (Fig.  5).  B  JAB  inhibited 
the cytotoxicity to a  lesser extent;  NAD-7 and  Daudi  did  not  inhibit  at  all.  It is of 
interest that the uninfected Raji showed a slight but significant inhibition. Thus with 
the exception of Raji,  the capacity of the cell lines to inhibit  the killing of Raji  (V) 
was directly related to their NK susceptibility as targets. 
We  have  also  performed  the  reciprocal  experiment  with  Molt-4  as  targets.  Cell- 
mediated  lysis of the  Molt-4  could  be  inhibited  by both  Raji  (V)  and  Daudi  (V), 
whereas  uninfected  Raji  and  Daudi  were  ineffective  (Fig.  6).  In keeping with  their 
high NK sensitivity, Moh-4 and K562 were more efficient competitors than Raji (V). 
It is noteworthy that  uninfected  Raji  cells did not compete in this  system although 
they did compete against superinfected Raji cells as already mentioned (compare Fig. 620  EPSTEIN-BARR VIRUS SUPERINFECTION INCREASES SENSITIVITY 
TABLE  II 
NK Sensitivity of Different Cell Lines After Infection with P3HR-1  Virus 
Line 
Percentage of EA positive 
cells, experiment No. 
Percentage of specific 51Cr re- 
lease, experiment No. 
1  2  1  2 
%  % 
Raji (V)  25  25  27  56 
Raji  0  0  3  6 
Daudi (V)  41  45  40  48 
Daudi  1  1  1  6 
B  JAB (V)  25  11 
B  JAB  0  6 
AT-A-CL7-III (V)  11  15  5  17 
AT-A-CL7-III  0  0  2  9 
NAD-7 (V)  21  15  3  16 
NAD-7  0  5  0  4 
100:1 effector:target cell ratio in a 4-h assay 24 h after superinfection. 
TABLE  III 
Comparison of the Cytotoxicity of Lymphocytes Obtained  from EB V Antibody-positive 




EBV antibody-positive serum  EBV antibody-negative serum 
Raji  Raji (V)  Raji  Raji (V) 
% 
1  0  3  1  5 
2  9  0  15 
0  26 
0  32  0  47 
2  15  4  4 
0  24  0  16 
1  37 
3  1  27  0  32 
0  23 
4  0  17  2  27 
Mean  0.5  21.3  1.0  20.7 
* Percentage of specific SlCr release of Raji and Raji (V) targets.  The lymphocytes of 
seven EBV antibody-positive and 4 EBV antibody-negative donors  were tested. 
5).  The  cold-target  inhibition  experiments  indicate  that  the  cytotoxicity against  the 
superinfeeted  cells is mediated  by the same cells as the NK  phenomenon. 
Superinfection with Transforming  (B95-8)  Virus.  The  P3HR-1  virus is unique among 
EBV isolates in its ability to induce an abortively lyric cycle in Raji and certain other 
cell lines.  Wild  type  virus  transforms  normal  B  lymphocytes  into  established  lines, 
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FI•.  5.  Cold-target inhibition of the anti-Raji  (V) effect. The specific release of the uninhibited 
system was 34%. Inhibitor Raji (V) (Q), Molt-4 (I), K562 (1), Raft (©), B  JAB (O), Daudi (A), and 
NAD-7 ([]). The results represent the mean values of three experiments. 
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F[o. 6.  Cold-target inhibition of the lysis of Molt-4 cells. The specific release of the uninhibited 
system was 39%. Competitors are Moh-4 (I), K562 (Q), Raji (V) (O), Daudi (V) (A), Raji (O), and 
Daudi (A). Measured as percent specific 5~Cr release in a 4-h assay at a  100:1 effector:target cell 
ratio. 
nor does it induce any detectable EA. We tested the effect of transforming-B95-8 viral 
superinfection  on  the  NK  sensitivity  of  Raji  cells.  B95-8  virus  was  titrated  for 
infectivity by its ability to induce EBNA in the EBV-negative Ramos line (31). Two 
different virus pools were tested, one of them at three different concentrations.  B95-8 
virus exposure did not increase the NK sensitivity of Raji cells (Table IV). Daudi cells 
showed a certain increase in NK sensitivity although this was less dramatic than with 
P3HR-1  virus  (compare  Table  II).  EA  values  in  the  B95-8-infected  Daudi  cells, 
however, were not increased from the uninfected control cells (1%). 
Virus Induction with n-Butyrate.  Some EBV-carrying cells can be induced to express 
EA by iododeoxyuridine, bromodeoxyuridine, 12-O-tetradecanoyl-phorbol- 13-acetate 
(TPA), cyeloheximide, and n-butyrate  (26-30).  P3HR-1  cells could be induced more 
efficiently  than  Raji  by n-butyrate  as indicated  by the  appearance  of EA  (26).  We 
have  therefore  selected  P3HR-1  cell  to  test  the  effect  of n-butyrate  treatment  on 
cytotoxic sensitivity. The experiment  was complicated by the fact that P3HR-1  cells 
were sensitive to NK lysis. Their sensitivity was highly variable. This variation  may 
be related  to the  variable  proportion  of the cells  that  enter  spontaneously the  lytic 
cycle.  In spite  of this  variation,  the  experiments  showed  that  n-butyrate  induction 622  EPSTEIN-BARR  VIRUS  SUPERINFECTION  INCREASES  SENSITIVITY 
TABLE  IV 




Percentage of specific 51Cr release  Percentage of EA 
Raji  Raji  Daudi  Daudi 
(B95-8)  Daudi  (B95-8)  Daudi  (B95-8) 
%  % 
1  0  0  .... 
2  1  6  1  17  --  -- 
3  0  2  1  23  1  1 
4  0  0  1  8  --  -- 
5  2  3  .... 
Mean  0.6  2.5  1.0  16.0 
The virus was tested at three different concentrations. The virus used in experiments  1 and 
2  induced 24% EBNA in Ramos cells at a  1:5 dilution. The virus used in experiments 3, 4, 
and 5 induced 27% EBNA in Ramos cells at a  l:10 dilution. 
TABLE  g 
Increased Sensitivity of n-Butyrate Treated P3HR-1 Cells 
Percentage of spe- 
Percentage ofspe-  cific SlCr release in  Experiment  Duration of n*bu-  cific ~lCr release, 
No.  tyrate treatment  control  n-butyrate-treated 
cells 
h  %  % 
1  24  0  5 
2  24  5  11 
3  24  46  56 
4  40  15  22 
5  48  24  31 
4  X  10  ~  P3HR-1  cells  per  ml  were  incubated  with  3  mM  n-butyrate  for 
different time intervals. Sensitivity to killing by blood lymphocytes was meas- 
ured as specific 51Cr release at a  100:1  effector:target cell ratio in a  4-h assay. 
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FIc.  7.  Sensitivity ofn-butyrate-treated cells. 0.4 ×  10  6  P3HR-1  cells were induced with 3 mM  n- 
butyrate and used as targets in a  4-h 51Cr-release assay at a  100:1 effector target:cell ratio. Induced 
cells are (O), control P3HR-I  cells are ([~). B. BLAZAR, M.  PATARROYO, E. KLEIN, AND G. KLEIN 
TABLE VI 
Induction  with n-Butyrate  Causes a Parallel Increase in NK Sensitivity and 
EA Expression 
Treatment  Percentage of spe- 
cific 51Cr release  Percentage of EA 
%  % 
None  0  4 
Induction for 24 h  5  15 
Induction for 48 h  8  24 
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regularly increased cytotoxicity (Table V), as assessed after 24-48 h. When followed 
as a  function of time during a  2-d period, sensitivity increased with time (Fig. 7), in 
parallel with the EA values (Table VI). 
Thus, induction of the EBV cycle by both chemical and viral agents increases the 
NK sensitivity of the human lymphoid lines. 
Discussion 
NK cells in the blood or spleen lymphocyte population of healthy individuals or 
unmanipulated experimental animals affect, in vitro, certain tumor-derived cell lines. 
There is considerable interest in the NK effect because it may contribute to immune 
surveillance. In part, this assumption  is based on the fact that  highly sensitive cell 
lines are derived from tumors. High sensitivity is the property of cultured cells. This 
may indicate that NK-sensitive cells are eliminated in vivo and survive only in vitro, 
when released from the pressure of the NK cells. 
The nature of the killing is unknown. The sensitive cell panel does not provide any 
clue for the cell surface structure that serves as the target. The majority of investigators 
agree that the NK system lacks selectivity. Lymphocytes of different individuals differ 
in their killing efficiency but the ranking order of relative sensitivity remains similar 
when a spectrum of targets are confronted with different effector cells. 
Cell lines can be divided into three categories: (a) sensitive in short-term assay;  (b) 
sensitive only in long-term assay;  (c) insensitive. The difference between the first and 
second  categories  is  probably  quantitative,  in  that  a  target  displays  sensitivity  to 
effectors with a certain threshold level of activity. During prolonged interaction, the 
potentially cytotoxic lymphocytes are activated to kill with a higher efficiency. 
We have shown that the relatively low NK sensitivity of human EBV-carrying B- 
cell lines can be increased by superinfection with the abortively lytic P3HR-1 virus or 
with n-butyrate, but not with the transforming EBV-prototype, the B95-8 virus. The 
increased  NK  sensitivity was  maintained  in  the  presence of Ara-C  (Unpublished 
results.). When considered together with the kinetics of the effect, the findings suggest 
that the increased vulnerability by NK cells may develop in relation to the entry of 
the cells into the viral cycle. If this mechanism also operates in vivo, it may obviously 
help in restricting the spread of virus, by killing potential virus-producing cells before 
they reach the stage where they can release mature virus particles. 
Lymphocytotoxicity was truly natural, i.e., it did not depend on previous immu- 
nization with the virus or with viral antigens. Lymphocytes of EBV-seropositive and 
-seronegative donors were equally effective. 624  EPSTEIN-BARR  VIRUS SUPERINFECTION INCREASES SENSITIVITY 
The relationship  between  the  lysis of the virally superinfeeted cells and  the  NK 
system was most clearly demonstrated by cold-target competition experiments. They 
indicated that the same effector cells operated in both. The ability of other cell lines, 
including  EBV-genome-negative  lines,  to  compete  for  the  cytotoxic  effectors  was 
clearly related to their NK sensitivity. 
The  mechanism  of increased  NK  sensitivity  in  the  virally  infected  cells  is  not 
known.  It is not merely a  sign of increased membrane fragility, because the sponta- 
neous release did not differ between infected and noninfected target cells. Moreover, 
the cells were harvested 24-48 h after infection, at the time when there is not yet any 
appreciable cell death as a  result of the superinfection process. We have excluded all 
cultures with <85% viable cells. 
The most convincing demonstration of a specific membrane change after superin- 
fection,  as  opposed  to  a  general  increase  in  membrane  fragility  comes  from  the 
competition test. Superinfected cells competed in a known NK system, the lysis of the 
high NK-sensitive target, Molt-4. 
Although the mechanism by which EBV-superinfection increases NK sensitivity to 
the  target  is  not  known,  extrapolation  from  experimental  evidence  indicates  that 
interferon may play an important role (42).  Brief interferon treatment of lymphocytes 
increases their lytic potential, so that they may even affect otherwise NK-insensitive 
targets (43).  The possibility that interferon, produced by the virally infected cells, is 
responsible for the induction of the cytotoxic effectors is unlikely, because B95-8 virus, 
but  not  P3HR-1  virus, superinfection  was found  to act as an interferon  inducer  in 
EBV-carrying, latently infected lines (44). In fact, interferon was not detected in the 
supernates of the P3HR-1  virus superinfected  Raji cells. 2 The ability of the superin- 
fected cells to compete in  the system with  Moh-4,  as target, speaks for an induced 
membrane claange that renders the cells more sensitive to NK lysis. 
Recently  Pdarson  et  al.  (39)  showed  Raji  (V)  cells  are  sensitive  to  antibody- 
dependent  lymphocytotoxicity  exerted  by  anti-EBV  antibody-positive  serum  and 
lymphocytes  of healthy  donors.  In  current  experiments,  we  could  confirm  these 
findings  and  found  that  the  ADCC  effect  was  superimposed,  over and  above the 
viraUy induced NK sensitivity. 
Summary 
Superinfection  of latently  Epstein-Barr  virus  (EBV)-carrying Raji  cells with  the 
P3HR- 1 substrain of EBV, known to induce the entry of a substantial fraction of the 
cells  into  an  abortively  lytic  cycle,  increased  the  susceptibility  of the  cells  to  the 
natural  killer  (NK)  effect  of  human  blood  lymphocytes.  Reciprocal  cold-target 
competition  tests  with  known  NK-cell  sensitive  and  -resistant  lymphoid  cell  lines 
showed  that  the  increased  susceptibility  is  a  result  of the  appearance  of an  NK- 
sensitive target, rather than to a general increase in membrane fragility. 
Lymphocytes  of  EBV-seropositive  and  -negative  donors  were  equally  effective 
killers against  P3HR-1  virus-superinfected  targets.  EBV-induced  NK sensitivity in- 
creased with time. It was a result of some event associated with the intracellular viral 
cycle, and  not  to  the  adherence  of viral particles  to  the  cell  surface.  Induction  of 
EBV-carrying P3HR-1 cells to entry into the viral cycle with n-butyrate also increased 
2  We are grateful to Dr. Wolfgang Berthold of the Karolinska  Institute for testing the supernates of Raji 
(V) for the presence of interferon. B.  BLAZAR, M.  PATARROYO,  E.  KLEIN, AND G.  KLEIN  625 
their NK sensitivity. A  transforming, noneytopathic prototype strain of EBV, B95-8, 
failed to increase the susceptibility of the Raji cells to NK-lysis, although it had some 
effect on the Daudi line. 
Because NK cells can kill virus-producing cells at an early stage of the cycle, before 
the virus particles  are assembled,  they may restrict,  in vivo, the spread  of the virus 
from latently infected cells. 
We would like to express our thanks to Agneta Manneborg, Ingrid Eriksson, Kerstin Falk, and 
Ann Christin Synnerhoim for valuable technical assistance. 
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